Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

CTIP2 may help in skin development and maintenance.

Fusaric acid may help control Orobanche ramosa by activating plant defenses.

A new laser technique can precisely remove specific cell types in living animals without harming nearby cells.

The laser system helps study brain cell functions by precisely removing specific cells and observing changes.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Fatp4 is crucial for healthy skin development and function.

A young woman developed facial bumps before hair loss, which is unusual for her condition.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

The "Two-Cell Assemblage" assay is a new, simple method to identify substances that may promote hair growth.

LPA 4 helps control blood and lymph vessel development in zebrafish.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.